Trial Profile

Safety and Immunogenicity of Measles Vaccine, Varicella Vaccine and Hepatitis-A Vaccine in HIV-exposed and HIV-unexposed South African Children

Status: Active, no longer recruiting

Phase of Trial: Phase IV

Latest Information Update: 06 Dec 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Hepatitis A vaccine inactivated (Primary) ; Measles vaccine (Primary) ; Varicella zoster virus vaccine live (Primary)
Indications Hepatitis A; Measles; Varicella zoster virus infections
Focus Pharmacodynamics
Acronyms MV/VV/Hep-AV

Most Recent Events

15 Mar 2020 Status changed from recruiting to active, no longer recruiting.
17 Feb 2020 Planned End Date changed from 1 Jun 2019 to 1 Dec 2022.
17 Feb 2020 Status changed from completed to recruiting.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com